MAOLAC

MAOLAC
Develops precision proteins for impact nutrition using proteomics and bioinformatics.
About
What does MAOLAC do?
MAOLAC develops advanced colostrum-based biofunctional ingredients inspired by human breast milk. Using proprietary AI technology, they identify and validate natural proteins with high structural and functional similarity to human proteins, creating clinically proven, high-potency ingredients for human health applications. Their products are designed for specific conditions, offering easy formulation and effectiveness at low daily dosages.
What is MAOLAC's revenue?
StartupHub estimates MAOLAC's annual revenue at $3.4M (range $1.9M to $8.5M, 69% confidence), based on comparable companies in the sector.
Where is MAOLAC headquartered?
MAOLAC is headquartered in Rehovot, Israel.
When was MAOLAC founded?
MAOLAC was founded in 2017.
What industry does MAOLAC operate in?
MAOLAC operates in Healthcare, Life Sciences, Biotech, Nutrition, Food, Computational Biology.
How many employees does MAOLAC have?
MAOLAC has approximately 18 people on record.
Galatek develops AI-driven automation solutions for life sciences laboratories and advanced semiconductor manufacturing, focusing on precision and reproducibility.
Digital batch record software for pharmaceutical and biotech manufacturing.
Biotalent is a platform that streamlines biotech hiring by connecting qualified candidates with job opportunities and providing hiring teams with tools for efficient candidate review.
AI-powered platform accelerating biological research and drug discovery.
A healthcare and life sciences consulting firm leveraging AI and data analytics for strategic solutions.
Empowering Life Science Entrepreneurs for Innovative Healthcare Solutions.
An entrant is a company tagged Life Sciences whose domain was first registered in the window, counted from registry records in the StartupHub directory. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.